Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Active, Not Recruiting

Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT04747613

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • City Of Hope National Med Center Duarte, California, United States
  • City Of Hope Duarte, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
View all 60 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

NCT04576156

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Hematologic Diseases, +6 more
Locations
  • University of California-San Diego/Moores UCSD Cancer Center La Jolla, California, United States
  • UCLA David Geffen School of Medicine Los Angeles, California, United States
  • Smilow Cancer Center at YNHH New Haven, Connecticut, United States
  • BRCR Medical Center Inc Plantation, Florida, United States
View all 144 locations
View Trial Details
Active, Not Recruiting

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

NCT02935361

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +14 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

NCT04217356

Conditions
Bone Marrow Cancer, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • Nova Scotia Health Authority Halifax, Nova Scotia, Canada
View Trial Details
Active, Not Recruiting

CINC424A2X01B Rollover Protocol

NCT02386800

Conditions
Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +31 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Wooloongabba, Queensland, Australia
  • Novartis Investigative Site Bedford Park, South Australia, Australia
View all 97 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants With Previously Treated Myelofibrosis

NCT04562870

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
  • Illinois Cancer Specialist Niles, Illinois, United States
  • Texas Oncology - Northeast Texas Tyler, Texas, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion

NCT03722407

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details

Related conditions